Medical journal questioning findings of hydroxychloroquine coronavirus study

British medical journal the Lancet on Tuesday said it had concerns about data behind an influential article that found hydroxychloroquine increased the risk of death in COVID-19 patients, a conclusion that undercut scientific interest in the medicine championed by U.S. President Donald Trump.

Hydroxychloroquine – which has anti-inflammatory and antiviral properties – inhibited the coronavirus in laboratory experiments but has not been proven effective in humans, particularly in placebo-controlled, randomized clinical trials considered the gold standard for data.

The debate has become highly politicized, and many scientists have voiced concern.

(Video from May 22)

1:54Coronavirus outbreak: Study finds hydroxychloroquine may be tied to higher fatality risk for COVID-19 patients

Coronavirus outbreak: Study finds hydroxychloroquine may be tied to higher fatality risk for COVID-19 patients

Nearly 150 doctors signed an open letter to the Lancet last week calling the article’s conclusions into question and asking to make public the peer review comments that preceded publication.

Story continues below advertisement

“This is not some sideshow or minor issue,” said Dr. Walid Gellad,

 » READ MORE FROM GLOBAL NEWS

Do you have a news tip or a story idea?

Send it our way!

Get the News in Your Inbox Daily!

Powered by:

This site uses cookies to provide you with a great user experience. By continuing to use this website, you consent to the use of cookies in accordance with our privacy policy.

Scroll to Top